On November 12, Lindsay Bealor Greenleaf, the head of federal and state policy at ADVI Health, discussed what to expect in regard to healthcare policy ahead of a second Trump administration with AJMC – The American Journal of Managed Care’s article, The Trump Sequel: What to Expect on PBMs, 340B, Drug Pricing, and RFK Jr.

In the article, Lindsay expands on several issues in addition to PBMs, 340B, drug pricing, and RFK Jr, like issues Trump considered bringing to fruition in his first term, like the International Pricing Index model, Most Favored National model, Medicare Advantage (MA) expansion, and attempts to repeal the Affordable Care Act (ACA).

Read Lindsay’s insights in AJMC.